Advancing Cancer Care for Dogs

Peer Reviewed by Nature™: Remarkable Survival Gains for Canine Cancer Patients. See how we work with:

Read press coverage of our latest peer-reviewed paper:


FidoCure® Precision Medicine for Canine Cancer

Pet Parents


There’s no “one-size-fits-all” treatment for cancer. That’s why FidoCure® uses genomic testing to determine the best course of action for your dog’s cancer therapy – beyond standard chemo and radiation.

FidoCure® Approach: Genetic testing reveals which targeted therapies may work best for your dog

Precision medicine can offer a hopeful prognosis.  FidoCure® was created by dog lovers and scientists on a mission to make effective canine cancer treatment accessible.  Our process uses genomic testing in conjunction with tumor type to identify possible cancer-causing mutations. From there, we suggest targeted therapy to precisely attack the cancer cells.

Forrest was diagnosed with splenic cancer and given one month to live.

Through the targeted therapy suggested by FidoCure®, he lived happily for nearly 4 years past his diagnosis.

“Thank you for your support and for opening the door to those four wonderful extra years.”
— Grace , CT

Forrest, Golden Retriever

Hemophagocytic Histiocytic Sarcoma

Trusted by the Leading Veterinary Oncologists

We believe that targeted therapy will be the standard of care for veterinary oncology in the near future.
— Dr. Gerald Post, DVM, MEM, DACVIM
Chief Veterinary Officer, One Health Company

Thousands of dogs have benefitted from FidoCure® when other options were limited.

Resources & Education